ArticleTherapeutics and clinical risk management2023

LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis.

Tao Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.